TALEA GROUP S.P.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.1 EUR | -0.33% |
|
+13.38% | -30.21% |
| 04-23 | Talea closes first quarter with revenues up | AN |
| 03-29 | Talea at a loss in 2023; revenues up 13 percent | AN |
| Sales 2024 * | 169M 181M 247M | Sales 2025 * | 206M 221M 302M | Capitalization | 41.71M 44.6M 60.97M |
|---|---|---|---|---|---|
| Net income 2024 * | -1M -1.07M -1.46M | Net income 2025 * | 3M 3.21M 4.39M | EV / Sales 2024 * | 0.45 x |
| Net Debt 2024 * | 34.15M 36.51M 49.92M | Net Debt 2025 * | 32.3M 34.54M 47.21M | EV / Sales 2025 * | 0.36 x |
| P/E ratio 2024 * |
-37.1
x | P/E ratio 2025 * |
13
x | Employees | 200 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 25.12% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -0.33% | ||
| 1 week | +13.38% | ||
| Current month | +7.39% | ||
| 1 month | -0.97% | ||
| 3 months | -29.40% | ||
| 6 months | -29.07% | ||
| Current year | -30.21% |
1 week
4.95
6.20
1 month
4.956.42
Current year
4.959.20
1 year
4.9511.80
3 years
4.9535.40
5 years
4.9545.80
10 years
4.9545.80
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 60 | 12-11-29 | |
Marco Baroni
DFI | Director of Finance/CFO | - | 22-05-02 |
Alberto Maglione
BRD | Director/Board Member | 45 | 12-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 60 | 12-11-29 | |
| Director/Board Member | 71 | - | |
Alberto Maglione
BRD | Director/Board Member | 45 | 12-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 6.1 | -0.33% | 4,733 |
| 24-04-25 | 6.12 | 0.00% | 18,167 |
| 24-04-24 | 6.12 | +15.47% | 26,074 |
| 24-04-23 | 5.3 | +4.74% | 26,170 |
| 24-04-22 | 5.06 | -5.95% | 30,399 |
Real-time Borsa Italiana, April 26, 2024 at 11:44 am
More quotes
Talea Group SpA is an Italy-based company specialized healthcare and wellness products. It manages an e-shop and different stores in Tuscany with a wide offering, which includes cosmetics, pharmaceuticals, medical devices, food supplements and alternative medicines, among others. The Company is active locally.
Sector
Internet Services
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.1
EUR
Average target price
11.25
EUR
Spread / Average Target
+84.43%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -30.21% | 44.53M | |
| -2.53% | 184B | |
| -11.62% | 180B | |
| -8.43% | 91.88B | |
| +41.15% | 91.6B | |
| -10.53% | 71.28B | |
| +19.26% | 26.35B | |
| +17.48% | 10.05B | |
| -11.43% | 8.53B | |
| -15.19% | 5.59B |
- Stock Market
- Equities
- FAR Stock
